You just read:

Zacks.com ETF Strategist Eric Dutram highlights: Intercept Pharma (ICPT) Pushes SPDR Biotech ETF Ahead of Rivals

News provided by

Zacks Investment Research, Inc.

Jan 13, 2014, 09:30 EST